Gianluca Campo

Research interests

Publications

• Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2300468

• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

  Circulation · 2022 · https://doi.org/10.1161/circulationaha.122.061612

• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

  Circulation · 2022 · https://doi.org/10.1161/circulationaha.122.061612

• Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(20)32519-8

• Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmc2009166

• Complete Revascularization with Multivessel PCI for Myocardial Infarction

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1907775

• Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31872-0

• Prognostic Value of QFR Measured Immediately After Successful Stent Implantation

  JACC: Cardiovascular Interventions · 2019 · https://doi.org/10.1016/j.jcin.2019.06.003

• Five-Year Outcomes with PCI Guided by Fractional Flow Reserve

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1803538

• Diagnostic Performance of In‐Procedure Angiography‐Derived Quantitative Flow Reserve Compared to Pressure‐Derived Fractional Flow Reserve: The FAVOR II Europe‐Japan Study

  Journal of the American Heart Association · 2018 · https://doi.org/10.1161/jaha.118.009603

• Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31714-8

• Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)32050-5

• Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis

  BMC Medicine · 2016 · https://doi.org/10.1186/s12916-016-0763-7

• Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates

  Journal of the American College of Cardiology · 2015 · https://doi.org/10.1016/j.jacc.2014.11.053

• Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial Infarction

  JAMA · 2005 · https://doi.org/10.1001/jama.293.17.2109

Current projects

No projects listed.